Cold-Defense
Natural health product licensed in Canada
- Other names
- Health First Cold Defense
- Licence holder
- Health First Network
- NPN or DIN-HM
- 80090613
- Status
- Active licence
- Licence date
- 14 February 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Andrographis paniculata (Burm. f.) Nees: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Agastache rugosa Source : Sommité Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 150 milligramme | 30 milligramme | Not calculated |
| Astragalus membranaceus Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 100 milligramme | 10 milligramme | Not calculated |
| Saposhnikovia divaricata Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 150 milligramme | 30 milligramme | Not calculated |
| Panax quinquefolius Source : Racine Potency : 5 % Ginsenosides | 200 milligramme | Not calculated |
| Andrographis paniculata Source : Feuille Potency : 30 % Andrographolide | 70 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | minimum: 1 Capsule ; maximum: 3 Capsule | 3 days |
Uses authorised in Canada
For relief of cold symptoms.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if pregnant or breast feeding.
- Effets indésirables connus
None.
- Précautions et mises en garde
Consult a health care practitioner before use if you have a bleeding disorder or hormone-sensitive cancer, or if you have an auto immune disorder and/or are taking immunosuppressants. Consult a health care practitioner prior to use if you are taking blood thinners or digoxin or if you have diabetes. Consult a health care practitioner if symptoms persist or worsen.
Source
Official Health Canada record, licence 80090613
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.